(Q37148508)

English

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

scientific article published on 17 October 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

author name string

J Honnorat

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

S Cartalat-Carel

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

D Ricard

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J Ph Camdessanche

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

A F Carpentier

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

V Rogemond

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

F Chapuis

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

M Aguera

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

E Decullier

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

A M Duchemin

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

F Graus

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J C Antoine

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

17 October 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

80

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

412-416

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Primary sensory neuropathy with muscular changes associated with carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Recommended diagnostic criteria for paraneoplastic neurological syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Anti-CV2 autoantibodies and paraneoplastic neurological syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

6 September 2017

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

29 September 2017

Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

27 June 2018

POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

27 June 2018

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

27 June 2018

Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

3 September 2018

Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

3 September 2018

Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

3 September 2018

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

3 September 2018

Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664637

3 September 2018

Paraneoplastic peripheral neuropathy associated with anti‐Hu antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18931014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18931014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18931014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.2007.138016

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37148508&oldid=2110191815"